Why does intraocular pressure (IOP) decrease after phacoemulsification cataract extraction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanisms of IOP Reduction After Phacoemulsification

Phacoemulsification reduces intraocular pressure primarily through improved aqueous humor outflow dynamics resulting from anatomical changes in the anterior chamber, with the magnitude of reduction strongly predicted by preoperative lens vault, baseline IOP, and anterior chamber angle parameters.

Primary Anatomical Mechanisms

The IOP reduction after phacoemulsification occurs through several interconnected anatomical changes:

Anterior Chamber Deepening and Angle Widening

  • Removal of the crystalline lens eliminates anterior lens vault, which directly increases anterior chamber depth, area, and volume 1, 2
  • The mean AOD500 (angle opening distance) increases significantly postoperatively, creating more space in the angle structures 1, 2
  • This anatomical widening improves access to the trabecular meshwork and enhances conventional aqueous outflow 2

Enhanced Trabecular Meshwork Function

  • Greater preoperative lens vault correlates strongly with greater IOP reduction (r-value = 0.606), suggesting that relieving mechanical compression on angle structures is a key mechanism 2
  • Eyes with smaller preoperative TISA (trabecular iris space area) and AOD experience greater IOP reduction, indicating that crowded angles benefit most from the space created by lens removal 2

Magnitude and Predictors of IOP Reduction

Expected IOP Changes

  • Average IOP reduction ranges from 1.8 to 2.4 mm Hg in various populations, with effects persisting for at least 1-2 years 3, 1, 2
  • In primary open-angle glaucoma patients, the reduction can be more substantial (mean 2.9 mm Hg decrease from 18.1 to 15.2 mm Hg) 4
  • Patients with exfoliation syndrome demonstrate greater IOP reduction (-1.85 mm Hg) compared to controls (-0.62 mm Hg), possibly related to irrigation volume during surgery 5

Key Predictive Factors

  • Higher preoperative IOP strongly predicts greater postoperative IOP reduction (r-value = 0.73), suggesting a regression to mean effect combined with improved outflow 3, 2
  • Older age and deeper preoperative anterior chamber depth are associated with lower postoperative IOP 3
  • Smaller preoperative AOD and TISA values predict greater IOP reduction, as these eyes have more room for improvement 2

Clinical Considerations and Caveats

Variable Response Patterns

  • Approximately 38% of medically controlled glaucoma patients may require additional medications or experience IOP increases within the first postoperative year despite the average reduction 3
  • Both closed-angle and open-angle glaucoma eyes show similar IOP reductions (approximately 2 mm Hg at 12 months), though angle opening is more pronounced in open-angle eyes 1
  • Postoperative IOP spikes occur in 25-34% of patients regardless of exfoliation status, requiring vigilant early postoperative monitoring 5

Medication Reduction Benefits

  • In glaucoma patients, the average number of antiglaucoma medications decreases significantly (from 1.7 to 0.7 medications) alongside IOP reduction 4
  • This medication reduction represents an important quality of life benefit beyond the numerical IOP decrease 4

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.